<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82690">
  <stage>Registered</stage>
  <submitdate>25/03/2008</submitdate>
  <approvaldate>3/04/2008</approvaldate>
  <actrnumber>ACTRN12608000161325</actrnumber>
  <trial_identification>
    <studytitle>Ultrasound Guided Transversus Abdominis Plane Block in Major Gynaecological Surgery  A randomised controlled Trial</studytitle>
    <scientifictitle>A randomised placebo-controlled double-blind trial assessing the analgesic efficacy of ultrasound guided transversus abdominis plane local anaesthetic block in major gyanae-oncological surgery</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil Known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Post-operative Pain</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Ultrasound guided transversus abdominis plane (TAP) local anaesthetic blockade.  This involves two injections of 20ml 0.5% ropivicaine (total 40ml).  The injections take around 10 minutes to perform.</interventions>
    <comparator>ultrasound guided TAP blockade with normal saline</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Pain Score (Visual Analogue Scale) &gt; 50mm with forced expiration</outcome>
      <timepoint>2 hours post-intervention</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>VAS &gt;50mm with forced expiration</outcome>
      <timepoint>24 hours post-intervention</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Total Morphine Consumption</outcome>
      <timepoint>2 and 24 hours post-intervention</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Adult females scheduled to undergo laparotomy via midline incision for known or suspected gynae-oncology</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>inability/unwillingness to provide informed consent, allergy/sensitivity to any of the protocol medications, patient or treating anaesthetist preference to use epidural (or other) analgesia</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>A randomisation table will allocate the 70 patients in the study to either treatment or placebo.  The hospital pharmacy will make up syringes containing either local anaesthetic or placebo in accordance with the randomisation table.  They will then be labelled with Study Patient 1, Study Patient 2, etc. but not the contents.</concealment>
    <sequence>A computer generated random number table will be used for sequence generation (eg. www.random.org)</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/10/2008</anticipatedstartdate>
    <actualstartdate>3/12/2008</actualstartdate>
    <anticipatedenddate />
    <actualenddate>7/10/2009</actualenddate>
    <samplesize>70</samplesize>
    <actualsamplesize>72</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>James Griffiths</primarysponsorname>
    <primarysponsoraddress>Department of Anaesthesia
Royal Women's Hospital
Grattan St
Carlton Vic. 3053</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Department of Anaesthesia, Royal Women's Hospital</fundingname>
      <fundingaddress>Grattan St
Carlton Vic. 3053</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Department of Anaesthesia, Royal Women's Hospital</sponsorname>
      <sponsoraddress>Grattan St
Carlton Vic. 3053</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The project aims to demonstrate that transversus abdominis plane block is an effective adjunct to multi-modal analgesia in the setting of major gynaecological surgery via midline laparotomy.  The project aims to demonstrate that the technique improves overall pain relief, reduces morphine consumption (and opioid side effects) and improves patient satisfaction.</summary>
    <trialwebsite />
    <publication>Griffiths JD, Middle J, Barron F, Grant S, Popham P, Royse C. Transversus abdominis plane block does not provide additional benefit to multimodal analgesia in gynaecological cancer surgery. Anaesth Analg, 111(3): 797-801 (2010)</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Women's Hospital Research and Ethics Committee</ethicname>
      <ethicaddress>Grattan St, 
Parkville Vic 3052</ethicaddress>
      <ethicapprovaldate>1/11/2008</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>7/05/2008</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Dr James Griffiths</name>
      <address>Royal Women's Hospital
Grattan St
Carlton Vic. 3053</address>
      <phone>+61383452381</phone>
      <fax>+61383452379</fax>
      <email>james.griffiths@rwh.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dr James Griffiths</name>
      <address>Royal Women's Hospital
Grattan St
Carlton Vic. 3053</address>
      <phone>+614 18306793</phone>
      <fax>+613 94971739</fax>
      <email>james.griffiths@rwh.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr James Griffiths</name>
      <address>Royal Women's Hospital
Grattan St
Carlton Vic. 3053</address>
      <phone>+61383452381</phone>
      <fax>+61383452379</fax>
      <email>james.griffiths@thewomens.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>James Griffiths</name>
      <address>Department of Anaesthesia
Royal Women's Hospital
Grattan St
PARKVILLE Vic 3052</address>
      <phone>+61383452381</phone>
      <fax />
      <email>james.griffiths@thewomens.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>